# ORTHOPEDIC COMPETITIVE INTELLIGENCE PLATFORM - ENHANCEMENT PRD
## Phase 2 & 3 Development Requirements

### PRODUCT OVERVIEW
Transform the existing multi-category medical device competitive intelligence platform from MVP to enterprise-grade SaaS solution for marketing firms.

**Current State**: Working MVP with 4 device categories (cardiovascular, spine fusion, joint replacement, diabetes care) deployed on Streamlit Cloud with authentication.

**Target State**: Enterprise platform with advanced intelligence capabilities, multi-tenant architecture, and white-label customization.

### BUSINESS OBJECTIVES

#### Phase 2: Advanced Intelligence (Week 3-4)
- **Regulatory Analysis**: Track FDA submissions, approvals, warning letters for 20+ medical device companies
- **Pricing Intelligence**: Provide market pricing insights across 4 device categories
- **Clinical Evidence Mining**: Extract insights from peer-reviewed publications and clinical trials
- **Enhanced Search**: Category-specific query templates for comprehensive research

#### Phase 3: Platform Scaling (Week 5-6)  
- **Multi-Tenant Architecture**: Support 5+ marketing firms using platform simultaneously
- **Historical Tracking**: Track competitive landscape changes over 6+ months
- **White-Label Capability**: Custom branding for marketing firm client reports
- **Enterprise Performance**: Handle 50+ concurrent analyses across tenants

### TARGET USERS
**Primary**: Marketing professionals at marketing firms serving medical device manufacturers
**Secondary**: Individual consultants and smaller marketing agencies
**Enterprise**: Large marketing firms with multiple medical device clients

### TECHNICAL REQUIREMENTS

#### Phase 2 Technical Specifications
1. **New LangGraph Nodes**
   - regulatory_analysis_node(): FDA submission tracking
   - pricing_intelligence_node(): Market pricing research  
   - clinical_evidence_node(): Publication mining

2. **Enhanced Data Models**
   - RegulatoryInsight: FDA submissions, approvals, concerns
   - PricingInsight: Market pricing, reimbursement, positioning
   - ClinicalEvidence: Study results, publication analysis

3. **Search Template Extensions**
   - Regulatory templates for FDA research
   - Pricing templates for market analysis
   - Clinical templates for publication mining

#### Phase 3 Technical Specifications
1. **Database Layer**
   - PostgreSQL/SQLite for persistent storage
   - MarketingFirm, CompetitiveAnalysis, CompetitiveTrend models
   - Multi-tenant data isolation

2. **Authentication System**
   - API key-based tenant authentication
   - Usage limits and rate limiting
   - White-label configuration management

3. **Historical Tracking**
   - CompetitiveTrendTracker for change detection
   - Trend analysis over time
   - Automated alerts for competitive changes

### PERFORMANCE REQUIREMENTS
- **Phase 2**: <8 minutes total analysis time (allowing +3 minutes for new features)
- **Phase 3**: <5 second analysis start time with 10 concurrent users
- **Memory**: <4GB total usage across all tenants
- **Database**: <2 second query response times
- **Uptime**: 99.9% reliability for enterprise users

### QUALITY REQUIREMENTS
- **Regulatory Accuracy**: 85%+ of FDA submissions correctly identified
- **Pricing Relevance**: 80%+ of pricing insights actionable for marketing
- **Clinical Evidence**: 90%+ of publications relevant to competitive analysis
- **Data Isolation**: 100% separation between marketing firm tenants
- **Backward Compatibility**: All existing functionality preserved

### SECURITY REQUIREMENTS
- **Data Isolation**: Complete tenant data separation
- **API Key Encryption**: Secure credential storage
- **Audit Logging**: All actions logged with tenant context
- **Rate Limiting**: Per-tenant usage controls
- **Data Retention**: Configurable retention policies

### SUCCESS METRICS

#### Phase 2 Success Criteria
- Regulatory analysis identifies FDA submissions for 90%+ of queries
- Pricing intelligence provides actionable insights for 80%+ of analyses
- Clinical evidence mining finds relevant publications for 90%+ of competitors
- Analysis time remains under 8 minutes
- All existing spine fusion functionality preserved

#### Phase 3 Success Criteria  
- 3+ marketing firms actively using multi-tenant platform
- 15+ medical device companies tracked across all tenants
- Professional-grade white-labeled reports generated
- Platform handles 50+ concurrent analyses
- Zero data leakage between tenants in security testing

### IMPLEMENTATION CONSTRAINTS
- **No Breaking Changes**: Existing users must be unaffected
- **Backward Compatibility**: Current API endpoints must continue working
- **Performance**: No degradation for single-tenant usage
- **Security**: Enterprise-grade data protection required
- **Rollback Capability**: All features must be reversible

### RISK MITIGATION
- **Feature Flags**: Enable gradual rollout of new capabilities
- **Progressive Enhancement**: Add features without breaking existing functionality
- **Comprehensive Testing**: 90%+ test coverage for all new features
- **Performance Monitoring**: Continuous monitoring with automatic alerts
- **Security Validation**: Penetration testing for multi-tenant features

### DEPLOYMENT STRATEGY
- **Phase 2**: Incremental deployment with feature flags
- **Phase 3**: Progressive rollout starting with single test tenant
- **Rollback Plan**: Maintain single-tenant fallback mode
- **Monitoring**: Real-time performance and security monitoring

This PRD defines the requirements for transforming the orthopedic competitive intelligence platform from a working MVP into an enterprise-grade SaaS solution that marketing firms can use for comprehensive competitive intelligence operations. 